Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pathol Res Pract ; 216(5): 152910, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32139257

RESUMO

PURPOSE: Protein phosphatase 4 catalytic subunit (PP4C) has been shown to play crucial regulatory roles in biological process and is frequently upregulated in cancer such as breast and colorectal carcinoma. However, the function and potential molecular mechanism of PP4C in lung cancer remains unclear. METHODS: Bioinformatic analysis was used to detect the expression level and prognosis of patients. Western blot, quantitative real-time PCR (qRT-PCR), CCK8, 5-Ethynyl-2'-deoxyuridine (Edu) proliferation assay and flow cytometric were used to explore the function in lung cancer cells. RESULTS: In this study, we found that PP4C was upregulated in lung cancer tissues as compared with that in normal lung tissues. Furthermore, patients with high expression level of PP4C were correlated with a poor prognosis in lung cancer patients. In vitro, CCK8, Edu proliferation assays and flow cytometry analysis showed that PP4C could promote lung cancer cell growth and inhibit apoptosis. Mechanistic investigations revealed that PP4C may interact with PP4R1 and promote ERK activation. Additionally, PP4C depletion resulted in lower tumor growth in vivo. CONCLUSIONS: Taken together, these data showed the oncogenic of PP4C in NSCLC tumorigenesis and provide a new insight of PP4C in the progression of NSCLC.


Assuntos
Carcinoma Pulmonar de Células não Pequenas/patologia , Neoplasias Pulmonares/patologia , Sistema de Sinalização das MAP Quinases/fisiologia , Fosfoproteínas Fosfatases/metabolismo , Apoptose/fisiologia , Biomarcadores Tumorais/análise , Biomarcadores Tumorais/metabolismo , Proliferação de Células/fisiologia , Humanos , Prognóstico , Regulação para Cima
2.
Math Biosci Eng ; 16(6): 6350-6366, 2019 07 09.
Artigo em Inglês | MEDLINE | ID: mdl-31698566

RESUMO

Secret image sharing has been widely applied in numerous areas, such as military imaging systems, remote sensing, and so on. One of the problems for image sharing schemes is to efficiently recover original images from their shares preserved by the shareholders. However, most of the existing schemes are based on the assumption that the shares are distortion-free. Moreover, the correspondence between secret images and their shares is definite. To overcome these shortcomings, we propose a novel secret sharing scheme using multiple share images based on the generalized Chinese remainder theorem (CRT) in this paper, where all of the shares are needed to recover the original images. Two categories of distortions are considered. In the first category, some pairs of shares with the same moduli are exchanged, while in the second category, some of pixels in the pairs of shares with the same moduli are exchanged. Based on these two sharing methods, we propose a generalized CRT based recovery method. Compared with the existing CRT based methods as well as combinatorial based methods, the proposed approach is much more efficient and secure. Furthermore, the conditions for successful recovery of two images from the given distorted shares are obtained. Simulations are also presented to show the efficiency of the proposed scheme.

3.
Drug Metab Pers Ther ; 30(4): 215-30, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26457791

RESUMO

Clinical pharmacy service is focused on the rationality and safety of medication therapy. Clinical pharmacists play an important role in designing therapeutic regimen, preventing medication errors, reducing the incidence of adverse drug reaction, and saving medical costs. Although clinical pharmacy service in China is in its early stage, its development is rapid. In this manuscript, the working model of clinical pharmacists in a Chinese tertiary hospital is introduced, including ward rounds, consultation, stewardship of antimicrobial therapy, drug adverse reaction monitoring, therapeutic drug monitoring, clinical pharmacokinetics and pharmacogenetics, and training system. With the efforts of clinical pharmacists, there will be a significant increase in the optimization of medication therapy and a notable reduction in preventable adverse drug events as well as health-care cost in China.


Assuntos
Farmacêuticos/organização & administração , Serviço de Farmácia Hospitalar/organização & administração , Centros de Atenção Terciária/organização & administração , Sistemas de Notificação de Reações Adversas a Medicamentos/organização & administração , Sistemas de Notificação de Reações Adversas a Medicamentos/normas , China , Competência Clínica/normas , Monitoramento de Medicamentos/métodos , Monitoramento de Medicamentos/normas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/prevenção & controle , Educação em Farmácia/organização & administração , Educação em Farmácia/normas , Humanos , Uso Excessivo dos Serviços de Saúde/prevenção & controle , Equipe de Assistência ao Paciente/organização & administração , Equipe de Assistência ao Paciente/normas , Farmacêuticos/normas , Farmacogenética , Serviço de Farmácia Hospitalar/normas , Prática Profissional/organização & administração , Prática Profissional/normas , Centros de Atenção Terciária/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...